ALEVIATE human coagulation factor VIII 250IU / von Willebrand Factor 600IU powder for injection vial with diluent vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

Factor VIII, Quantity: 250 IU; Von willebrand factor, Quantity: 600 IU

Tillgänglig från:

CSL Behring Australia Pty Ltd

INN (International namn):

Factor VIII,Von willebrand factor

Läkemedelsform:

Injection, diluent for

Sammansättning:

Excipient Ingredients:

Administreringssätt:

Intravenous

Enheter i paketet:

Glass vial containing 250 IU FVIII, 500 IU vWF supplied with 1 x 5mL diluent vial

Receptbelagda typ:

Not scheduled. Not considered by committee

Terapeutiska indikationer:

The prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. The prophylaxis and treatment of non-surgical and surgical bleeding associated with factor VIII deficiency due to haemophilia A.

Produktsammanfattning:

Visual Identification: Clear and colourless; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2010-05-21